Phenytoin Suspension
NDC Package 51672-4069-2
Package Information
Phenytoin suspension is phenytoin is used to prevent and control seizures (also called an anticonvulsant or antiepileptic drug). This formulation utilizes a suspension delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-4069 and is authorized under FDA application ANDA040521.
Identification & Billing
- RxCUI: 1313112 - phenytoin 125 MG in 5 mL Oral Suspension
- RxCUI: 1313112 - phenytoin 25 MG/ML Oral Suspension
- RxCUI: 1313112 - DPH 25 MG/ML Oral Suspension
- RxCUI: 1313112 - phenytoin 100 MG per 4 ML Oral Suspension
- RxCUI: 1313112 - phenytoin 125 MG per 5 ML Oral Suspension
Clinical Specifications
- Anti-epileptic Agent - [EPC] (Established Pharmacologic Class)
- Cytochrome P450 1A2 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2B6 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C19 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C8 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C9 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2D6 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inducers - [MoA] (Mechanism of Action)
- Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-4069 - Phenytoin
- 51672-4069-2 - 1 BOTTLE in 1 CARTON / 237 mL in 1 BOTTLE
- 51672-4069 - Phenytoin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-4069). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-4069-2 identifies a specific commercial package of 1 bottle in 1 carton / 237 ml in 1 bottle of Phenytoin, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This suspension is formulated for oral use and contains phenytoin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on April 08, 2004. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Phenytoin is used to prevent and control seizures (also called an anticonvulsant or antiepileptic drug). It works by reducing the spread of seizure activity in the brain.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672406902. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.